Thursday, May 17, 2012
Canada OKs Osiris drug; first stem cell therapy
BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment